Irreversible Electroporation for Locally Advanced Pancreatic Cancer

被引:3
|
作者
Timmer, Florentine E. F. [1 ]
Geboers, Bart [1 ]
Ruarus, Alette H. [1 ]
Schouten, Evelien A. C. [1 ]
Nieuwenhuizen, Sanne [1 ]
Puijk, Robbert S. [1 ]
de Vries, Jan J. J. [1 ]
Meijerink, Martijn R. [1 ]
Scheffer, Hester J. [1 ]
机构
[1] Vrije Univ, Canc Ctr Amsterdam, Amsterdam Univ, Dept Radiol & Nucl Med,Med Ctr, Amsterdam, Netherlands
关键词
irreversible electroporation; image-guided; ablation; locally advanced pancreatic; cancer; immunomodulation; immunotherapy; abscopal effect; KILLER-CELL IMMUNOTHERAPY; IN-VIVO; INDUCTION CHEMOTHERAPY; THERMAL ABLATION; TUMORS; SAFETY; LIVER; EFFICACY; FEASIBILITY; COMBINATION;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Several minimally invasive image guided tumor ablation techniques have been added to the treatment spectrum for locally advanced pancreatic cancer (LAPC). Irreversible electropo- ration (IRE) might have a significant additive value in the management of this difficult - to -treat disease. As opposed to thermal ablative techniques, IRE induces cell death by the delivery of high - voltage electrical pulses. The electrical energy disrupts the cellular membrane integrity, causes loss of cellular homeostasis and ultimately results in cell death. The extracellular matrix of connective tissue in surrounding delicate structures such as bile ducts, bowel wall, and larger blood vessels is spared. The preservation of these structures makes IRE attractive for the treatment of pancreatic cancers that are unresectable due to their anatomical location (ie, LAPC and local recurrence after surgical resection). In addition to its cytoreductive abili- ties, evidence is emerging on IRE?s capability to induce systemic immunomodulation through active in vivo vaccination against pancreatic cancer cells. These effects in combination with immunotherapy may offer a new treatment paradigm for tumors with low immunogenic poten- tial like pancreatic ductal adenocarcinoma (PDAC). This review discusses several practical and technical issues of IRE for LAPC: clinical evaluation, indications, patient preparations, procedural steps, imaging characteristics, clinical results, and ?tricks of the trade? used to improve the safety and efficacy of the treatment. Future directions such as the combination of IRE with immunotherapy will be shortly addressed. Tech Vasc Interventional Rad 23:100675 (c) 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license. (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer
    He, Chaobin
    Sun, Shuxin
    Zhang, Yu
    Li, Shengping
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 4795 - 4807
  • [42] INITIAL EXPERIENCE OF IRREVERSIBLE ELECTROPORATION IN THE TREATMENT OF LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA
    Welden, Charles V.
    Christein, John D.
    Wilcox, Charles M.
    Ahmed, Ali M.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S277 - S277
  • [43] Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma
    Leen, Edward
    Picard, John
    Stebbing, Justin
    Abel, Mark
    Dhillon, Tony
    Wasan, Harpreet
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (02) : 275 - 281
  • [44] Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer
    Yang-Yang Ma
    Yin Leng
    Yan-Li Xing
    Hong-Mei Li
    Ji-Bing Chen
    Li-Zhi Niu
    [J]. World Journal of Clinical Cases, 2020, 8 (22) : 5564 - 5575
  • [45] The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy
    Ansari, Daniel
    Kristoffersson, Stina
    Andersson, Roland
    Bergenfeldt, Magnus
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (11) : 1165 - 1171
  • [46] Percutaneous Irreversible Electroporation for Ablation of Locally Advanced Pancreatic Cancer Experience From a Chinese Institution
    Zhang, Yishi
    Shi, Juanjuan
    Zeng, Jianying
    Alnagger, Mohammed
    Zhou, Liang
    Fang, Gang
    Long, Xin'an
    Pan, Zhongbao
    Li, Yanhong
    Chen, Jibing
    Xu, Kecheng
    Qian, Wei
    Niu, Lizhi
    [J]. PANCREAS, 2017, 46 (02) : E12 - E14
  • [47] Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer
    Ma, Yangyang
    Xing, Yanli
    Li, Hongmei
    Liang, Bing
    Li, Rongrong
    Li, Jianyu
    Li, Zhonghai
    Lin, Mao
    Niu, Lizhi
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [48] Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer
    Ma, Yang-Yang
    Leng, Yin
    Xing, Yan-Li
    Li, Hong-Mei
    Chen, Ji-Bing
    Niu, Li-Zhi
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (22) : 5564 - 5575
  • [49] Irreversible electroporation as treatment option within a multidisciplinary approach for locally advanced pancreatic cancer.
    Ricker, Ansley Beth
    Iannitti, David A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 727 - 727
  • [50] Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC)
    Oikonomou, Dimitrios
    Karamouzis, Michalis V.
    Moris, Dimitrios
    Dimitrokallis, Nikolaos
    Papamichael, Demetris
    Kountourakis, Panteleimon
    Astras, Georgios
    Davakis, Spyridon
    Papalampros, Alexandros
    Schizas, Dimitrios
    Petrou, Athanasios S.
    Felekouras, Evangelos
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (07): : 325 - 330